- Report
- July 2022
- 100 Pages
Global
From €2642EUR$2,750USD£2,259GBP
- Report
- April 2023
- 135 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- April 2023
- 115 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- March 2021
- 498 Pages
Global
From €8643EUR$8,995USD£7,389GBP
- Report
- March 2021
- 478 Pages
United States
From €7682EUR$7,995USD£6,568GBP
- Report
- March 2020
China
From €7682EUR$7,995USD£6,568GBP
- Report
- February 2020
Japan
From €7682EUR$7,995USD£6,568GBP
- Report
- February 2020
India
From €7682EUR$7,995USD£6,568GBP
- Report
- February 2020
Australia
From €7682EUR$7,995USD£6,568GBP
- Report
- February 2021
- 100 Pages
Global
From €4324EUR$4,500USD£3,697GBP
- Report
- July 2018
- 56 Pages
India
From €4799EUR$4,995USD£4,103GBP
- Report
- July 2018
- 213 Pages
United States
From €4799EUR$4,995USD£4,103GBP
- Report
- July 2018
- 55 Pages
Canada
From €4799EUR$4,995USD£4,103GBP
- Report
- July 2018
- 51 Pages
Australia
From €4799EUR$4,995USD£4,103GBP
- Report
- July 2018
- 47 Pages
China
From €4799EUR$4,995USD£4,103GBP
- Report
- July 2018
- 49 Pages
South Korea
From €4799EUR$4,995USD£4,103GBP
- Report
- July 2018
- 60 Pages
Germany
From €4799EUR$4,995USD£4,103GBP
- Report
- February 2023
- 123 Pages
United Kingdom
From €3839EUR$3,995USD£3,282GBP
- Report
- February 2023
- 120 Pages
Italy
From €3839EUR$3,995USD£3,282GBP
- Report
- February 2023
- 124 Pages
Germany
From €3839EUR$3,995USD£3,282GBP
Orthobiologics is a field of biotechnology that focuses on the development of products and treatments to improve musculoskeletal health. It includes the use of biological materials such as stem cells, growth factors, and proteins to repair, regenerate, and replace damaged or diseased tissues. Orthobiologics is used to treat a variety of musculoskeletal conditions, including fractures, tendon and ligament injuries, and degenerative joint diseases. It is also used to improve the healing of bone and soft tissue after surgery.
Orthobiologics is a rapidly growing field, with new products and treatments being developed to improve patient outcomes. It is becoming increasingly important in the treatment of musculoskeletal conditions, as it offers a more natural and less invasive approach than traditional treatments.
Some companies in the Orthobiologics market include Acelity, AlloSource, Arthrex, Bioventus, DePuy Synthes, Exactech, Integra LifeSciences, Medtronic, MiMedx, Orthofix, and Stryker. Show Less Read more